Peer review reports
From: Prevention and control of non-communicable diseases in iran: the case for Investment
Original Submission | ||
---|---|---|
5 Sep 2021 | Submitted | Original manuscript |
Resubmission - Version 2 | ||
Submitted | Manuscript version 2 | |
Resubmission - Version 3 | ||
Submitted | Manuscript version 3 | |
23 Nov 2021 | Reviewed | Reviewer Report - Mehrnoosh Emadi |
7 Apr 2022 | Reviewed | Reviewer Report |
6 May 2022 | Author responded | Author comments - Mahmood Yousefi |
Resubmission - Version 4 | ||
6 May 2022 | Submitted | Manuscript version 4 |
9 May 2022 | Author responded | Author comments - Mahmood Yousefi |
Resubmission - Version 5 | ||
9 May 2022 | Submitted | Manuscript version 5 |
13 May 2022 | Author responded | Author comments - Mahmood Yousefi |
Resubmission - Version 6 | ||
13 May 2022 | Submitted | Manuscript version 6 |
17 May 2022 | Reviewed | Reviewer Report - Mehrnoosh Emadi |
27 May 2022 | Reviewed | Reviewer Report |
Resubmission - Version 7 | ||
Submitted | Manuscript version 7 | |
Publishing | ||
6 Jun 2022 | Editorially accepted | |
24 Jun 2022 | Article published | 10.1186/s12889-022-13615-w |